4-Isopropyl-thiazolidin | 23990-63-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 4-Isopropyl-thiazolidin
• 英文别名: 4-Propan-2-yl-1,3-thiazolidine
• CAS: 23990-63-8
• 化学式: C₆H₁₃NS
• mdl: MFCD19218220
• 分子量: 131.242
• InChiKey: OOFCJUORNUCTAI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  聚合甲醛 、 2-isopropyl-aziridine 在 硫化氢 作用下， 生成 4-Isopropyl-thiazolidin
  参考文献：
  名称：

  Larice,J.-L.; Roggero,J., Bulletin de la Societe Chimique de France, 1971, p. 2053 - 2056

  摘要：

  DOI：

文献信息

• 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
  申请人：Hutchinson H. John

  公开号：US20070105866A1

  公开（公告）日：2007-05-10

  Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

  本发明描述了调节5-脂氧合酶激活蛋白(FLAP)活性的化合物和含有该化合物的药物组合物。本发明还描述了单独使用和与其他化合物联合使用FLAP调节剂，用于治疗呼吸系统、心血管系统和其他白三烯依赖性或白三烯介导的状况或疾病。
• Anti-Viral Compounds
  申请人：DeGoey David A.

  公开号：US20100168138A1

  公开（公告）日：2010-07-01

  Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

  描述了一种有效抑制丙型肝炎病毒（“HCV”）复制的化合物。本发明还涉及制备这种化合物的方法、包含这种化合物的组合物，以及使用这种化合物治疗HCV感染的方法。
• [EN] AMINOPYRIDINE DERIVATIVES<br/>[FR] DÉRIVÉS D'AMINOPYRIDINE
  申请人：VANTIA LTD

  公开号：WO2009133348A1

  公开（公告）日：2009-11-05

  The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R1 - R11 are as defined herein.

  本发明提供了式（I）的化合物：包含这些化合物的组合物；在治疗中使用这些化合物（例如哮喘或COPD）；以及使用这些化合物治疗患者的方法；其中R1 - R11如本文所定义。
• 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
  申请人：Hutchinson John H.

  公开号：US20090221574A1

  公开（公告）日：2009-09-03

  Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

  本文描述了包含这些化合物的药物组合物，这些化合物调节5-脂氧合酶活化蛋白（FLAP）的活性。本文还描述了使用这样的FLAP调节剂的方法，单独或与其他化合物结合，用于治疗呼吸系统、心血管系统和其他依赖于白三烯或介导白三烯的疾病或病症。
• Substituted Amidine Compounds for Combating Animal Pests
  申请人：Kaiser Florian

  公开号：US20110257011A1

  公开（公告）日：2011-10-20

  The invention relates to substituted amidine compounds of formula (I), to the enantiomers, diastereomers and salts thereof and to compositions comprising such compounds. The invention also relates to the use of the substituted amidine compounds, of their salts or of compositions comprising them for combating animal pests. Furthermore the invention relates also to methods of applying such substituted amidine compounds. The substituted amidine compounds of the present invention are defined by the following formula I: wherein A 1 to A 4 , B 1 to B 3 , R 1 to R 3 , (R 4 ) p , (R 5 ) q , X and Y are defined as in the description.

  本发明涉及公式（I）的取代氨基化合物，其对映异构体、对映异构体和其盐以及含有这种化合物的组合物。本发明还涉及使用取代氨基化合物、其盐或含有它们的组合物来对抗动物害虫。此外，本发明还涉及应用这种取代氨基化合物的方法。本发明的取代氨基化合物由以下公式I定义：其中A1到A4，B1到B3，R1到R3，（R4）p，（R5）q，X和Y如描述中所定义。